Anath Shalev, M.D.
Division of Endocrinology, Diabetes & Metabolism
Areas of expertise:
- Diabetes research, drug discovery, and novel treatment approaches
- Beta cell and islet biology
- Type 1 diabetes
- Type 2 diabetes
Shalev is an expert in the field of diabetes and in developing disease-changing therapy regimens. She is the director of UAB’s Comprehensive Diabetes Center and her research includes basic, translational and clinical work as it relates to the study of diabetes.
- Targeting a microRNA could improve diabetes treatment with GLP-1 drugs, FierceBiotech
- Diabetics who use verapamil have lower glucose levels, data show, Science Daily